Yue Sun1, Chengli Du2, Bo Wang1, Yanling Zhang1, Xiaoyan Liu1, Guoping Ren3. 1. Department of Pathology, The First Affiliated Hospital, Zhejiang University Medical College, Hangzhou, China. 2. Department of Hepatobiliary Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. 3. Department of Pathology, The First Affiliated Hospital, Zhejiang University Medical College, Hangzhou, China. Electronic address: renguoping12345@163.com.
Abstract
BACKGROUND: eEF1A2 is a protein translation factor involved in protein synthesis, which possesses important function roles in cancer development. This study aims at investigating the expression pattern of eEF1A2 in prostate cancer and its potential role in prostate cancer development. METHODS: We examined the expression level of eEF1A2 in 30 pairs of prostate cancer tissues by using RT-PCR and immunohistochemical staining (IHC). Then we applied siRNA specifically targeting eEF1A2 to down-regulate its expression in DU-145 and PC-3 cells. Flow cytometer was used to explore apoptosis and Western-blot was used to detect the pathway proteins of apoptosis. RESULTS: Our results showed that the expression level of eEF1A2 in prostate cancer tissues was significantly higher compared to their corresponding normal tissues. Reduction of eEF1A2 expression in DU-145 and PC-3 cells led to a dramatic inhibition of proliferation accompanied with enhanced apoptosis rate. Western blot revealed that apoptosis pathway proteins (caspase3, BAD, BAX, PUMA) were significantly up-regulated after suppression of eEF1A2. More importantly, the levels of eEF1A2 and caspase3 were inversely correlated in prostate cancer tissues. CONCLUSION: Our data suggests that eEF1A2 plays an important role in prostate cancer development, especially in inhibiting apoptosis. So eEF1A2 might serve as a potential therapeutic target in prostate cancer.
BACKGROUND:eEF1A2 is a protein translation factor involved in protein synthesis, which possesses important function roles in cancer development. This study aims at investigating the expression pattern of eEF1A2 in prostate cancer and its potential role in prostate cancer development. METHODS: We examined the expression level of eEF1A2 in 30 pairs of prostate cancer tissues by using RT-PCR and immunohistochemical staining (IHC). Then we applied siRNA specifically targeting eEF1A2 to down-regulate its expression in DU-145 and PC-3 cells. Flow cytometer was used to explore apoptosis and Western-blot was used to detect the pathway proteins of apoptosis. RESULTS: Our results showed that the expression level of eEF1A2 in prostate cancer tissues was significantly higher compared to their corresponding normal tissues. Reduction of eEF1A2 expression in DU-145 and PC-3 cells led to a dramatic inhibition of proliferation accompanied with enhanced apoptosis rate. Western blot revealed that apoptosis pathway proteins (caspase3, BAD, BAX, PUMA) were significantly up-regulated after suppression of eEF1A2. More importantly, the levels of eEF1A2 and caspase3 were inversely correlated in prostate cancer tissues. CONCLUSION: Our data suggests that eEF1A2 plays an important role in prostate cancer development, especially in inhibiting apoptosis. So eEF1A2 might serve as a potential therapeutic target in prostate cancer.
Authors: Paula C Jimenez; Diego V Wilke; Paola C Branco; Anelize Bauermeister; Paula Rezende-Teixeira; Susana P Gaudêncio; Leticia V Costa-Lotufo Journal: Br J Pharmacol Date: 2019-12-23 Impact factor: 8.739
Authors: Alfonso Urbanucci; Stefan J Barfeld; Ville Kytölä; Harri M Itkonen; Ilsa M Coleman; Daniel Vodák; Liisa Sjöblom; Xia Sheng; Teemu Tolonen; Sarah Minner; Christoph Burdelski; Kati K Kivinummi; Annika Kohvakka; Steven Kregel; Mandeep Takhar; Mohammed Alshalalfa; Elai Davicioni; Nicholas Erho; Paul Lloyd; R Jeffrey Karnes; Ashley E Ross; Edward M Schaeffer; Donald J Vander Griend; Stefan Knapp; Eva Corey; Felix Y Feng; Peter S Nelson; Fahri Saatcioglu; Karen E Knudsen; Teuvo L J Tammela; Guido Sauter; Thorsten Schlomm; Matti Nykter; Tapio Visakorpi; Ian G Mills Journal: Cell Rep Date: 2017-06-06 Impact factor: 9.423
Authors: Thomas Stefan Worst; Frank Waldbillig; Abdallah Abdelhadi; Cleo-Aron Weis; Maria Gottschalt; Annette Steidler; Jost von Hardenberg; Maurice Stephan Michel; Philipp Erben Journal: BMC Urol Date: 2017-09-18 Impact factor: 2.264
Authors: Alejandro Losada; María José Muñoz-Alonso; Carolina García; Pedro A Sánchez-Murcia; Juan Fernando Martínez-Leal; Juan Manuel Domínguez; M Pilar Lillo; Federico Gago; Carlos M Galmarini Journal: Sci Rep Date: 2016-10-07 Impact factor: 4.379